Neurol. praxi. 2013;14(1):28-32

Late complications of Parkinson's disease

MUDr.Václav Dostál
Neurologická klinika, Pardubická krajská nemocnice a.s., Pardubice

Parkinson's disease is one of the most common neurodegenerative diseases. It manifests with a classic triad of symptoms (tremor, hypokinesia,

and rigidity). Establishing the diagnosis may be challenging and frequently takes several months. Dopamine replacement therapy is an effective



treatment: The treatment works very well in the first few years; afterwards, however, late complications start to develop and include both

motor and mental as well as autonomic ones. The disease is complex and cannot be limited to motor symptoms only. In the late stages, non-

-motor symptoms often affect the quality of life of the patient and his family more than motor symptoms do. The present paper aims to briefly

describe the most important late complications of this condition. Each thematic section is concluded with brief therapeutic recommendations.

complications.

Keywords: Parkinson's disease, wearing off, dyskinesias, continuous dopaminergic stimulation, depression, cognitive deficit, psychotic

Published: March 1, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Dostál V. Late complications of Parkinson's disease. Neurol. praxi. 2013;14(1):28-32.
Download citation

References

  1. Ahlskog JE, Muenter MD. Frequency of levodopa related dyskinesias and motor fluctuations as estimated form the cumulative literature. Mov Disrd 2001; 16: 448-458. Go to original source... Go to PubMed...
  2. Abbott RD, Petrovitch H, WhiteLR. Frequency of bowel movements and the future risk of Parkinson disease. Neurology 2001; 57: 456-463. Go to original source... Go to PubMed...
  3. Bareš M. Pozdní hybné kompikace Parkinsonovy nemoci - wearing off a další motorické fluktuace. Neurol. praxi, 2008; 9(2): 96-99.
  4. Djaldetti R, Shifrin A, Rogowski Z, Sprecher E, Melamed E, Yarnitsky D. Quantiative meassurement of pain sensation in patients with Parkinson disease. Neurology 2004; 62: 2171-2175. Go to original source... Go to PubMed...
  5. Dubois B, Poklon B. Cognitive deficits in Parkinsons disease. J. Neruol 1997; 244: 2-8. Go to original source... Go to PubMed...
  6. Fowler CJ. Investigation and treatment of bladder and sexual dysfunkction in disease affecting the autonomic nervous systom. In: Mathias CJ, Bannister SR, et al. Autonomic Failure: A textbook of Clinical Disorders of the Autonomic Nervous System. 4th ed. London-Oxford, 1999; 30: 296-303.
  7. Gescheidt T, Bareš M. Patologické hráčství u pacientů s Parkinsonovou chorobou. Neurol. praxi 2009; 10: 107-109.
  8. Hely MA. Sydney Multicenter study of Parkinson disease: non L dopa responsive problems dominate at 15 years. Mov disord. 2005; 20(2): 190-199. Go to original source... Go to PubMed...
  9. Jankovic J, Azher SN. Camptocormia - pathogenesis, classification, and response to therapy: Neurology August 9, 2005; 65(3): 355-359. Go to original source... Go to PubMed...
  10. Jenner P. Preventing and controlling dyskinesia in Parkinsons disease - a view of current kowledge and future opportunities. Mov Disrod 2008; 23(Suppl 3): 585-598. Go to original source... Go to PubMed...
  11. Magalhaes M, Wenning GK, Daniel SE, Quinn NP. Autonomic dysfunction in pathologicaly confirmed multiple system atrophy and idiopathic Parkinson disease: a restrospective comparsion. Acta neruol scand 1995; 91: 98-102. Go to original source... Go to PubMed...
  12. Olanow CW, Agid Q, Mizuno Y, Albanese A, Bonuccelli U, Damier P, De Yebenes J, Gershanik O, Guttman M, Grandas F, Hallet M, Hormykiewicz O, Jenner P, Ketzenschlager R, Langston WJ, LeWitt P, Melamed E, Mena MA, Michel PP, Mytilineou C, Obeso JA, Poewe W, Quinn N, Raismann-Vozari R, Rajput AH, Rascol O, Sampaio C, Stocchi F. Levodopa in the treatment of PD. Mov Disord 2004; 19: 997-1003. Go to original source... Go to PubMed...
  13. Rektorová I. Léčba deprese u Parkinsonovy nemoci. Boehringer Ingelheim, 2005.
  14. Rektorová I. Psychiatrické symptompy Parkinsonovy nemoci: Diagnostika a léčba. Neurol. praxi: 2007; 8: 291-292.
  15. Roth J, Havránková P. Vztah motorických a non motorických symptomů Parkinsonovy nemoci k dopaminergní terapii, část první. Neruol. praxi, 2008; 9(1): 33-36.
  16. Roth J, Havránková P. Vztah motorických a non-motorických symptomů Parkinsonovy nemoci k dopaminergní terapii. Neurol. praxi 2008; 9: 100-103.
  17. Růžička E, Roth J, Kaňovský P, Sekyrová M, Urgošík D, Vladyka V. Parkinsonova nemoc a parkinsonské syndromy, Galen, 2000.
  18. Schrag A, Ben-Shlomo Y, Brown R, Quinn N. What contributes to quality of life in patiens with Parkinsons disease? J Neruol Neurosurg Psychiatriy 2000; 69: 308-312. Go to original source... Go to PubMed...
  19. Tolosa E, Katzenschlager R. Pharmacological management of Parkinson disease in: Jankovic, Tolosa: Parkinson disease and movement disorders, Lippincott Williams and Wilkins, 2007.




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.